Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Charles Elliott Sigal

At a glance: Charles Elliott Sigal is Director at Alnylam Pharmaceuticals (ALNY). Their latest SEC Form 4, filed Nov 12, 2026, reported a purchase of $244K. On file: 1 purchase line ($244K) and 0 sale lines ($0).

Disclosed holdings: about $533K of ALNY stock: 3,600 shares (including shares held indirectly, e.g. through a trust or fund) reported on their latest Form 4 (filed Nov 12, 2026), valued at the Nov 20, 2026 close of $147.97. This counts only ALNY shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Alnylam Pharmaceuticals, Inc. (ALNY)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$7K
Total bought / sold$244K / $0

Charles Elliott Sigal's InsiderPrint

4 trades from SEC Form 4 filings, 2023 to 2026, drawn as one fingerprint.

InsiderPrint of Charles Elliott Sigal: 4 trades, 2023 to 20262023: 3 buys, 0 sales2024: 0 buys, 0 sales2025: 0 buys, 0 sales2026: 1 buy, 0 sales

Reading this print: Almost only buys, trading about once a year, typically $64K a trade.

  • Bump outward: a purchase (4)
  • Dent inward: a sale (0)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Polly A. MurphyDirector · AVIR · 100% matchTheir buys since 2021: 2 of 3 beat the S&P 500
  2. Sachin M. ShivaramDirector · EAF · 100% match
  3. Nicholas T. LongDirector · AMCR · 100% match
  4. Timothy T. YatesDirector · VISN · 100% match
  5. T. Ritson FergusonDirector · HPP · 99% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Nov 12SEC ALNYAlnylam Pharmaceuticals, Inc.First buyStake +80% Buy 1,6003,600 held (+80%) $152.25 $244K -2.8%
  • Buy

    Director Charles Elliott Sigal bought $244K of ALNY at $152.25 — first open-market purchase in our records; raises the stake by 80%.

Follow Charles Elliott Sigal

Get one email when Charles Elliott Sigal files a new purchase or sale. Free.

At most one email a day about Charles Elliott Sigal, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.